AN OVERVIEW OF BIG DATA IN COVID-19 AS A CONTRIBUTION TO THE MANAGEMENT OF SCIENTIFIC AND TECHNOLOGICAL KNOWLEDGE
AN OVERVIEW OF BIG DATA IN COVID-19 AS A CONTRIBUTION TO THE MANAGEMENT OF SCIENTIFIC AND TECHNOLOGICAL KNOWLEDGE

Summary/Abstract: In times of pandemic, rapid sharing of research data is urgently needed, as is the intensification of networking. The COVID-19 pandemic brought a new perspective in relation to knowledge management in various organizational means, whether through the search for innovation or the improvement of its processes. Thus, to calculate the state of the art and track scientific and technological knowledge in the COVID-19 spectrum, the keyword “Coronavir*” was used in the PubMed and Espacenet databases. Data were processed by Carrot Search Lingo4G® and PatentInspiration®. In the Pubmed database, 1,000 documents were retrieved, which were organized into 81 groups of sub-themes, with emphasis on the sub-theme “treatment during coronavirus disease”, with 188 articles (18.8% of the total). Regarding technological innovation, China and the United States were the countries that filed the most patent applications, especially in 2020 and 2021, corresponding to 68.5% of the total. The first 4 (four) applicants with the highest number of patents were Pfizer, Gilead Sciences Inc., Center Nat Rech, Crucell Holland. The results obtained over a period of time demonstrate a partnership between universities and companies towards the fight against the pandemic. The tools for identifying, extracting and processing data (or free), are needed efficiently in the management of scientific and technological knowledge in COVID -19, thus being able to contribute to more assertive decision-making at various organizational levels.

• Details
• Contents